Cell therapy for recent heart attack with low heart pump
Part of Heart & circulation clinical trials.
This study tests a new cell therapy (MiSaver) for people who have had a heart attack and whose heart is not pumping as strongly as it should. It aims to see if these cells can help the heart recover when stents or bypass surgery aren't an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 or older and your body mass index (BMI) is 32 or less.
- Your heart attack was diagnosed between 36 hours and 7 days ago.
- Your heart's pumping strength is 45% or less (measured by LVEF), and you don't need medicine to keep your blood pressure up.
- Your cardiologist has decided that stents or bypass surgery are not right for you.
- You agree to use effective birth control during the study and for 6 months after, if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving specially prepared stem cells from your own blood can help your heart recover after a heart attack. You must have had a successful angioplasty or stenting within the last 4 weeks.
This trial tests if umbilical cord stem cells, given alongside standard care, can help people who have had a major heart attack (STEMI). The cells are infused into the heart artery to possibly improve heart function. You may qualify if you are between 20 and 76, had a heart attack within the last 12 hours, and received a stent, and your heart's pumping ability is moderately reduced.
This trial tests whether injecting special cells (HiCM-188) during bypass surgery can help improve heart function in people with advanced heart failure. The cells may help repair damaged heart tissue and improve your heart's ability to pump blood.
This trial tests whether injecting special cells (cell therapy) can help the heart recover in people with advanced heart failure who are getting a mechanical heart pump (LVAD). It may offer a new way to improve heart function and quality of life.
This Phase 1 study tests a treatment made from stem cells to grow heart muscle cells (“cardiomyocytes”) for people with long-lasting (chronic) heart weakness after a prior heart attack. It aims to see if the therapy can improve heart function and is safe in carefully selected patients.
This trial tests whether stem cells from donated umbilical cord blood can improve heart function in people with heart failure caused by blocked arteries. You'll receive one or more infusions of these cells through a vein.
Hear when a new Acute Myocardial Infarction (AMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.